Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for BPH
NCT01566292Phase 3Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in benign prostatic hyperplasia (BPH), sponsored by Università Cattolica del Sacro Cuore. Started Sep 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01566292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566292.